Living Donor Liver Transplantation With Two Stage Hepatectomy for Patients With Isolated, Irresectable Colorectal Liver Metastases

Program Status

Recruiting

Phase

Not Applicable

Prior Immunotherapy Allowed

No

CRC-directed Trial

Yes

Tags

MSI-H/ MMRd, MSS/ MMRp
Location Location Status
Germany
Jena University Hospital
Jena 07747
Recruiting
University Hospital Tübingen
Tübingen 72076
Recruiting

Contacts

Falk Rauchfuss, M.D., M.Sc.
CONTACT
004936419322601 Falk.Rauchfuss@med.uni-jena.de
Ulrike McCaulley, Study Nurse
CONTACT
004936419322694 Ulrike.McCaulley@med.uni-jena.de

Inclusion Criteria

Inclusion Criteria:

* Patients with irresectable colorectal liver metastases without extrahepatic tumor burden, except resectable pulmonary metastases
* stable disease or regression after at least eight weeks of systemic chemotherapy

Exclusion Criteria

Exclusion Criteria:

* comorbidities precluding liver transplantation
* extrahepatic tumor spread, except resectable pulmonary metastases
* progression during chemotherapy

NCT ID

NCT03488953

Date Trial Added

2018-04-05

Updated Date

2024-07-31